<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01727362</url>
  </required_header>
  <id_info>
    <org_study_id>ACU in breast cancer</org_study_id>
    <nct_id>NCT01727362</nct_id>
  </id_info>
  <brief_title>Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy</brief_title>
  <official_title>Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy- A Pragmatic Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mammazentrum Hamburg am Krankenhaus Jerusalem, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dorit und Alexander Otto Stiftung, Hamburg, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to investigate the effectiveness of acupuncture on quality of life
      in patients with breast cancer receiving chemotherapy compared to routine care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At the Mammazentrum Hamburg, Germany, patients with breast cancer receiving chemotherapy have
      the opportunity to get acupuncture in addition to conventional therapy to maintain quality of
      life and to reduce the side effects of the chemotherapy such as gastrointestinal disorders.
      In this randomized trial we aim to investigate the effectiveness of additional acupuncture
      compared to routine care in patients with breast cancer.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Pain, quality of sleep, and nausea (single items of the FACT-B)</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Pain, quality of sleep, and nausea (single items of the FACT-B)</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Functional Assessment of Chronic Illness Therapy-Fatigue</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Functional Assessment of Chronic Illness Therapy-Fatigue</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>FACT/GOG-NTX, polyneuropathy symptoms</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>FACT/GOG-NTX, polyneuropathy symptoms</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life (SF-12 Health Survey)</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life (SF-12 Health Survey)</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Survival without relapse</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Survival</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Adverse effects and Interactions</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Adverse effects and Interactions</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction and patient-reported effectiveness</measure>
    <time_frame>3 month</time_frame>
    <description>This will only be assessed in the acupuncture arm</description>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction and patient-reported effectiveness</measure>
    <time_frame>6 month</time_frame>
    <description>This will only be assessed in the acupuncture arm</description>
  </other_outcome>
  <other_outcome>
    <measure>Goal Attainment Scale</measure>
    <time_frame>3 month</time_frame>
    <description>This will only be assessed in the acupuncture arm</description>
  </other_outcome>
  <other_outcome>
    <measure>Goal Attainment Scale</measure>
    <time_frame>6 month</time_frame>
    <description>This will only be assessed in the acupuncture arm</description>
  </other_outcome>
  <other_outcome>
    <measure>Laboratory parameters (hemoglobin, leukocytes, blood plates, liver values, kidney values)</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Laboratory parameters (hemoglobin, leukocytes, blood plates, liver values, kidney values)</measure>
    <time_frame>6 month</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Usual care + acupuncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care + acupuncture</intervention_name>
    <description>Patients of this group receive a semi-standardized acupuncture treatment over 6 month in addition to usual care</description>
    <arm_group_label>Usual care + acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Patients of this group receive usual care only</description>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosed breast cancer (invasive, intraductal, hormone-sensitive and not
             hormone-sensitive, only locoregional metastases)

          -  current chemotherapy at Mammazentrum Hamburg with regimen FEC/DOC or EC/DOC

          -  willingness to receive acupuncture within the next 6 month if randomized in
             acupuncture group

          -  willingness to refrain from acupuncture within the next 6 month if randomized in
             control group

          -  informed consent

        Exclusion Criteria:

          -  distant metastases

          -  blood coagulation disorder and/or current use of anticoagulants

          -  serious acute or chronic mental or physical disorders

          -  clinically relevant cardiac arrhythmia symptoms

          -  insufficient German language ability
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Carstensen, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mammazentrum Hamburg am Krankenhaus Jerusalem</name>
      <address>
        <city>Hamburg</city>
        <zip>20357</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2012</study_first_submitted>
  <study_first_submitted_qc>November 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2012</study_first_posted>
  <last_update_submitted>July 21, 2017</last_update_submitted>
  <last_update_submitted_qc>July 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Claudia M. Witt</investigator_full_name>
    <investigator_title>Professor, MD</investigator_title>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>Acupuncture</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

